AC Immune announces a research and development collaboration in neurodegenerative diseases with Biogen

18.April 2016 08:00 CET

R&D collaboration to develop PET-ligands for two protein targets involved in pathogenesis of neurodegenerative diseases - alpha-synuclein and TDP43